Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular ropivacaine combinations for pain control after ACL surgery
IRCT20230626058586N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of ropivacaine, dexmedetomidine, magnesium sulfate and ketamine in postoperative pain (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pain intensity at 1 hour after operation, Pain intensity at 2 hours after operation and 3 more. Started Jan 2024; status: completed.
02
Drugs
ropivacainedexmedetomidinemagnesium sulfateketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20230626058586N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230626058586N2.